Company page
Keros Therapeutics, Inc.
Keros Therapeutics, Inc. is a public company traded under the ticker KROS in the American market. The company has a market capitalization of approximately $210.8 million. Keros Therapeutics focuses on developing innovative therapies for patients with rare diseases and unmet medical needs.
- Ticker
- KROS:NASDAQ
- Asset type
- Stock
- Market cap
- $210.8M
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- Exchange
- NASDAQ
- Currency
- USD